title: Toll-like receptor 9 interaction with CpG ODN--an in silico analysis approach.
abstract: BACKGROUND
  Toll-like receptor 9 (TLR9) recognises unmethylated CpG DNA and activates a signalling cascade, leading to the production of inflammatory cytokines such as TNF-α, IL-1, IL-6 and IL-12 via the adaptor protein MyD88. However, the specific sequence and structural requirements of the CpG DNA for the recognition of and binding to TLR9 are unknown. Moreover, the 3D structures of TLR9 and the TLR9-ODN complex have not been determined. In this study, we propose a reliable model of the interaction of the TLR9 ECD with CpG ODN using bioinformatics tools.
  
  
  RESULTS
  The three-dimensional structures of two TLR9 ECD-CpG ODN complexes were constructed using a homology modelling and docking strategy. Based on the models of these complexes, the TLR9 ECD-CpG ODN interaction patterns were calculated. The results showed that the interface between the human TLR9 and the CpG ODN molecule is geometrically complementary. The computed molecular interactions indicated that LRR11 is the main region of TLR9 that binds to CpG ODN and that five positively charged residues within LRR11 are involved in the binding of the TLR9 ECD to the CpG ODN. Observations in the close-up view of these interactions indicated that these five positively charged residues contribute differently to the binding region within the TLR9 ECD-CpG ODN complex. 337Arg and 338Lys reside in the binding sites of ODN, forming hydrogen bonds and direct contacts with the CpG ODN, whereas 347Lys, 348Arg, and 353His do not directly contact the CpG ODN. These results are in agreement with previously reported experimental data.
  
  
  CONCLUSIONS
  In this study, we present two structural models for the human and mouse TLR9 ECD in a complex with CpG ODN. Some features predicted by this model are consistent with previously reported experimental data. This complex model may lead to a better understanding of the function of TLR9 and its interaction with CpG ODN and will improve our understanding of TLR9-ligand interaction in general.
authors.affiliation: Beijing Institute of Biotechnology, Beijing 100071, China.
authors.forename: Wei
authors.initials: W
authors.lastname: Zhou
authors.forename: Yan
authors.initials: Y
authors.lastname: Li
authors.forename: Xichun
authors.initials: X
authors.lastname: Pan
authors.forename: Yuan
authors.initials: Y
authors.lastname: Gao
authors.forename: Beiping
authors.initials: B
authors.lastname: Li
authors.forename: Zhengliang
authors.initials: Z
authors.lastname: Qiu
authors.forename: Long
authors.initials: L
authors.lastname: Liang
authors.forename: Hong
authors.initials: H
authors.lastname: Zhou
authors.forename: Junjie
authors.initials: J
authors.lastname: Yue
mesh_terms: D000596:Amino Acids / Q000378:metabolism; D003198:Computer Simulation; D004247:DNA / Q000378:metabolism; D006801:Humans; D006860:Hydrogen Bonding; D057927:Hydrophobic and Hydrophilic Interactions; D000090263:Leucine-Rich Repeat Proteins; D008958:Models, Molecular; D009838:Oligodeoxyribonucleotides / Q000737:chemistry / Q000378:metabolism*; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011506:Proteins / Q000737:chemistry / Q000378:metabolism; D051217:Toll-Like Receptor 9 / Q000737:chemistry / Q000378:metabolism*
chemical_list: D000596:Amino Acids; C408982:CPG-oligonucleotide; D000090263:Leucine-Rich Repeat Proteins; D009838:Oligodeoxyribonucleotides; D011506:Proteins; D051217:Toll-Like Receptor 9; D004247:DNA